Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
The Neuromuscular Junction01:19

The Neuromuscular Junction

17.6K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
17.6K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Chemical Synapses01:26

Chemical Synapses

9.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.5K
Chemical Synapses01:26

Chemical Synapses

10.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developmental regulation of SMN expression: pathophysiological implications and perspectives for therapy development in spinal muscular atrophy.

Gene therapy·2017
Same author

ALS-Associated Endoplasmic Reticulum Proteins in Denervated Skeletal Muscle: Implications for Motor Neuron Disease Pathology.

Brain pathology (Zurich, Switzerland)·2016
Same author

The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.

Cell death and differentiation·2015
Same author

SC1/PRDM4 is a critical mediator for cell death, mitosis and differentiation of neural stem cells.

Journal of stem cells & regenerative medicine·2014
Same author

Molecular basis of neural repair mechanisms.

Cell and tissue research·2012
Same author

Ciliary neurotrophic factor (CNTF): physiological and pharmacological effects.

Restorative neurology and neuroscience·2011
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

6.4K

Motoneuron disease.

M Sendtner1

  • 1Institute for Clinical Neurobiology, University of Würzburg, Versbacherstr. 5, 97078, Würzburg, Germany, Sendtner_M@ukw.de.

Handbook of Experimental Pharmacology
|March 27, 2014
PubMed
Summary
This summary is machine-generated.

Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are motoneuron diseases where motor neurons degenerate. Neurotrophic factor signaling is disturbed, offering potential therapeutic targets for these neurodegenerative disorders.

More Related Videos

Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles
09:07

Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles

Published on: September 25, 2015

23.9K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

22.7K

Related Experiment Videos

Last Updated: May 1, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

6.4K
Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles
09:07

Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles

Published on: September 25, 2015

23.9K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

22.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are primary motoneuron diseases characterized by motor neuron dysfunction and degeneration.
  • While genetic causes for familial forms of ALS and SMA are identified, implicating RNA processing, protein aggregation, apoptosis, and energy metabolism, neurotrophic factor signaling pathways remain crucial for motor neuron health.
  • Dysregulation of these pathways is observed in both ALS and SMA, despite no direct genetic link to neurotrophic factors or their receptors.

Purpose of the Study:

  • To explore the role of neurotrophic factor signaling pathways in the pathogenesis of motoneuron diseases.
  • To investigate how these pathways interact with known disease mechanisms in ALS and SMA.
  • To identify potential therapeutic strategies for motoneuron diseases and other neurodegenerative conditions based on a deeper understanding of neurotrophic factor signaling.

Main Methods:

  • Review and synthesis of existing literature on the genetic basis of ALS and SMA.
  • Analysis of molecular mechanisms underlying motoneuron degeneration in ALS and SMA.
  • Examination of the involvement of neurotrophic factor signaling pathways in motor neuron survival, growth, and function.

Main Results:

  • Genetic defects in ALS and SMA highlight diverse mechanisms including RNA processing, protein aggregation, apoptosis, and energy metabolism.
  • Neurotrophic factor signaling pathways, essential for motor neuron survival and function, are demonstrably disturbed in both ALS and SMA.
  • These signaling pathways interact with established disease mechanisms, suggesting a complex interplay in motoneuron degeneration.

Conclusions:

  • Understanding the interplay between neurotrophic factor signaling and disease-specific mechanisms is critical for developing effective therapies for ALS and SMA.
  • Targeting neurotrophic factor pathways presents a promising avenue for treating motoneuron diseases and potentially other neurodegenerative disorders.
  • Further research into these signaling cascades could unlock novel therapeutic interventions for debilitating neurological conditions.